| 07:30 – 08:30 | Registration | ||
| 08:30 – 08:45 | Welcome Remarks | ||
| Session 1: Spondyloarthritis (SpA) | |||
| 08:45 – 09:10 | Recommendations on Early Diagnosis and Referral of Axial Spondyloarthritis (axSpA) |  Hanan Alrayes |
|
| 09:10 – 09:35 | Predictors of not Achieving Remission or Low Disease Activity in Axial Spondyloarthritis (axSpA) |  Ahmed Negm |
|
| 09:35 – 10:00 | Recommendations for the Management of Spondyloarthritis (SpA) Patients from Kuwait |  Adeeba Al-Herz |
|
| 10:00 – 10:15 | Difficult Spondyloarthritis (SpA) Cases |  Priyanka Moovara Cackamvalli |
|
| 10:15 – 10:35 | Panel Discussion | ||
| 10:35 – 11:05 | Industry Symposium by Novartis | Maisam Musgrave |
|
| 11:05 – 11:25 | Coffee Break & Poster Viewing Session | ||
| 11:25 – 11:55 | Industry Symposium by AbbVie | Ahmed Zayat |
|
| Session 2: Rheumatology & Central Nervous System (CNS) | |||
| 11:55 – 12:35 | Lupus, Hughes Syndrome & the Brain |  Graham Hughes |
|
| 12:25 – 12:40 | Cracking the Code: Navigating the Challenges of Neuropsychiatric Lupus | Deena Shaheen |
|
| 12:40 – 12:55 | Primary Central Nervous System (CNS) Vasculitis: Untangling the Diagnostic Quandary | Abdullatif Almehaideb |
|
| 12:55 – 13:10 | Panel Discussion | ||
| 13:10 – 15:15 | Lunch | ||
| Session 3: Systemic Lupus Erythematosus (SLE) | |||
| 15:15 – 15:45 | Industry Symposium by NewBridge | Karl Gaffney |
|
| 15:45 – 16:25 | Lupus Nephritis in the Gulf | Munther Khamashta |
|
| 16:25 – 16:40 | Digital Ischemia and Dry Gangrene as First Manifestation of Systemic Lupus Erythematosus (SLE) | Khalid Abdulrahman Altalhi |
|
| 16:40 – 17:00 | Diving Deep into Lupus: Gastrointestinal Involvement Insights from the Oman Lupus Study |  Nasra Al Adhoubi |
|
| 17:00 – 17:15 | Subconjunctival Hemorrhage as an Initial Presentation of Systemic Lupus Erythematosus (SLE) | Jawaher Enani |
|
| 17:15 – 17:35 | Panel Discussion | ||
| 17:35 – 18:05 | Industry Symposium by GSK | Mohamed Gamal |
|
*This program is subject to change without prior notice. Program as of 27 February 2024
| 07:00 – 08:00 | Registration | ||
| 08:00 – 08:05 | Welcome Remarks | Ayesha AlMheiri |
|
| Session 1: Genetics and Autoinflammatory Moderator: Elsadeg Sharif |
|||
| 08:05 – 08:35 | Role of Genetics in Pediatric Rheumatology | Maryam AlShehhi |
|
| 08:35 – 09:05 | Autoinflammation and Immunology: Bridging the Gaps | Shuayb Elkhalifa |
|
| 09:05 – 09:35 | Childhood Vasculopathy: New Insights | Sulaiman Al-Mayouf |
|
| 09:35 – 09:50 | Coffee Break | ||
| Session 2: Juvenile Rheumatoid Arthritis (JIA) Moderator:  Wafa Madan |
|||
| 09:50 – 10:20 | Screening Prior Initiation of Biologic Treatment | Hend Alkwai |
|
| 10:20 – 10:50 | Choice and Switch of Biologic Therapy in Juvenile Rheumatoid Arthritis (JIA) | Ayesha AlMheiri |
|
| 10:50 – 11:20 | Updates on Management of Uveitis in Children and Adolescent | Francesco Pichi |
|
| 11:20 – 11:50 | Secondary Osteoporosis in Children & Adolescents | Mohamed Zulficar Mughal |
|
| 11:50 – 12:05 | Coffee Break | ||
| Session 3: Childhood Onset Lupus Moderator : Nora Al Mutairi |
|||
| 12:05 – 12:35 | Childhood Lupus in Gulf: Are we Different? | Eman Al Masroori |
|
| 12:35 – 13:05 | Biomarkers in Lupus: Clinical Implications | Najla Aljaberi |
|
| 13:05 – 14:20 | Lunch | ||
| Session 4: Oral Abstracts and Challenging Cases Moderator: Reem Abdwani |
|||
| 14:20 – 14:40 | First Case Report of Omani Child with PRKCD Mutation with Monogenic Systemic Lupus Erythematosus (SLE) | Amani Al Ghadani |
|
| 14:40 – 15:00 | Rare and Fatal Interstitial Lung Disease (ILDs) as Complication of Systemic Juvenile Rheumatoid Arthritis (JIA) | Ikram Shaalan |
|
| 15:00 – 15:20 | STAT1 GOF Immundysregulation: A Case Report with CMC, Polyendocrinopathy, and Arthritis; Highlighting on the Efficacy of Adalimumab | Reima Bakry |
|
| 15:20 – 15:40 | Early Recognition, Multidisciplinary Approach, and Mortality Prevention: A Case of Macrophage Activation Syndrome at Presentation in a New Onset Juvenile Systemic Lupus Erythematosus (SLE) | Bushra Abu Saleh |
|
| 15:40 – 16:00 | Progressive Pseudo Rheumatoid Dysplasia Misdiagnosed as Juvenile Idiopathic Arthritis (JIA): Case Presentation | Duaa Hafiz |
|
*This program is subject to change without prior notice. Program as of 27 February 2024